Empirical Finance’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.79M | Buy |
7,273
+42
| +0.6% | +$16.1K | 0.15% | 138 |
|
|
2025
Q1 | $2.5M | Buy |
7,231
+118
| +2% | +$40.8K | 0.15% | 129 |
|
|
2024
Q4 | $2.13M | Sell |
7,113
-119
| -2% | -$35.7K | 0.12% | 150 |
|
|
2024
Q3 | $2.94M | Buy |
7,232
+98
| +1% | +$39.8K | 0.17% | 112 |
|
|
2024
Q2 | $2.29M | Sell |
7,134
-773
| -10% | -$248K | 0.14% | 127 |
|
|
2024
Q1 | $2.64M | Buy |
7,907
+231
| +3% | +$77K | 0.16% | 122 |
|
|
2023
Q4 | $2.08M | Sell |
7,676
-32
| -0.4% | -$8.66K | 0.14% | 138 |
|
|
2023
Q3 | $1.9M | Buy |
7,708
+439
| +6% | +$108K | 0.14% | 135 |
|
|
2023
Q2 | $2.21M | Buy |
7,269
+686
| +10% | +$208K | 0.17% | 117 |
|
|
2023
Q1 | $1.74M | Buy |
6,583
+231
| +4% | +$60.9K | 0.16% | 128 |
|
|
2022
Q4 | $1.52M | Buy |
6,352
+334
| +6% | +$80.1K | 0.16% | 135 |
|
|
2022
Q3 | $1.11M | Buy |
6,018
+870
| +17% | +$160K | 0.13% | 151 |
|
|
2022
Q2 | $865K | Buy |
5,148
+253
| +5% | +$42.5K | 0.11% | 176 |
|
|
2022
Q1 | $1.23M | Buy |
4,895
+468
| +11% | +$117K | 0.14% | 135 |
|
|
2021
Q4 | $1.14M | Buy |
4,427
+1,080
| +32% | +$277K | 0.13% | 134 |
|
|
2021
Q3 | $812K | Sell |
3,347
-4,129
| -55% | -$1M | 0.12% | 167 |
|
|
2021
Q2 | $1.55M | Sell |
7,476
-2,730
| -27% | -$565K | 0.25% | 82 |
|
|
2021
Q1 | $1.68M | Hold |
10,206
| – | – | 0.3% | 91 |
|
|
2020
Q4 | $1.68M | Buy |
10,206
+472
| +5% | +$77.6K | 0.3% | 91 |
|
|
2020
Q3 | $1.21M | Buy |
+9,734
| New | +$1.21M | 0.26% | 102 |
|